Carpal tunnel syndrome represents most common compressive neuropathy frequently exacerbated by diabetic microvasculatory impairment through median nerve ischemia and connective tissue fibrosis. Diabetes patients face elevated carpal tunnel syndrome risk yet frequently experience diagnostic delays compromising nerve recovery potential. 
In the study published in the Journal of Diabetes, the researchers analyzed 304 patients undergoing carpal tunnel release surgery who also carried diabetes diagnosis between 2012 and 2022 at tertiary care center capturing age and HbA1c alongside diagnostic timelines through comprehensive medical record review. They compared carpal tunnel syndrome to carpal tunnel release intervals between patients receiving diabetes diagnosis before versus after carpal tunnel syndrome identification.
Half of Surgical Patients Had Undiagnosed Diabetes
Investigators discovered 51% of patients received diabetes diagnosis following carpal tunnel syndrome identification confirming substantial under-recognition within compressive neuropathy population preceding metabolic characterization. Median interval between diabetes and carpal tunnel syndrome diagnoses proved equivalent at 24.6 months versus 24.3 months regardless of diagnostic sequence (p=0.604) establishing temporal diagnostic parity across subgroups.
Age and Poor Control Delay Surgical Intervention
Time from carpal tunnel syndrome diagnosis to first carpal tunnel release surgery averaged 2.5 months overall demonstrating rapid contemporary surgical triage yet exhibited modest prolongation among older patients through Spearman correlation coefficient of -0.24 at p<0.001 alongside HbA1c dependent delays reaching -0.15 correlation at p=0.002. Neither age nor HbA1c at diabetes diagnosis influenced surgical timelines confirming CTS-specific determinants predominate over antecedent metabolic chronology.
Routine Screening Essential for Diabetes Clinics
Endocrinologists must implement universal carpal tunnel syndrome symptom screening through Phalen maneuver and hand diagram assessment during initial diabetes evaluation targeting patients manifesting nocturnal paresthesias or grip weakness prompting early electrodiagnostic confirmation. Preoperative glycemic optimization below HbA1c 7.5% enhances median nerve recovery trajectories while multidisciplinary hand surgery referral pathways expedite release timing minimizing chronic denervation fibrosis among high-risk diabetic cohorts.